223 related articles for article (PubMed ID: 29981532)
1. Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
De Baets F; De Keyzer L; Van Daele S; Schelstraete P; Van Biervliet S; Van Braeckel E; Thomas M; Wanyama SS
Pediatr Allergy Immunol; 2018 Nov; 29(7):726-731. PubMed ID: 29981532
[TBL] [Abstract][Full Text] [Related]
2. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis.
Ritz N; Ammann RA; Casaulta Aebischer C; Schoeni-Affolter F; Schoeni MH
Eur J Pediatr; 2005 Sep; 164(9):577-82. PubMed ID: 15926067
[TBL] [Abstract][Full Text] [Related]
4. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.
Mastella G; Rainisio M; Harms HK; Hodson ME; Koch C; Navarro J; Strandvik B; McKenzie SG
Eur Respir J; 2000 Sep; 16(3):464-71. PubMed ID: 11028661
[TBL] [Abstract][Full Text] [Related]
5. Effect of allergic bronchopulmonary aspergillosis on FEV
Kaditis AG; Miligkos M; Bossi A; Colombo C; Hatziagorou E; Kashirskaya N; de Monestrol I; Thomas M; Mei-Zahav M; Chrousos G; Zolin A
Arch Dis Child; 2017 Aug; 102(8):742-747. PubMed ID: 28325727
[TBL] [Abstract][Full Text] [Related]
6. Immune responses to Aspergillus fumigatus and Pseudomonas aeruginosa antigens in cystic fibrosis and allergic bronchopulmonary aspergillosis.
Murali PS; Pathial K; Saff RH; Splaingard ML; Atluru D; Kurup VP; Fink JN
Chest; 1994 Aug; 106(2):513-9. PubMed ID: 7774329
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
Perisson C; Destruys L; Grenet D; Bassinet L; Derelle J; Sermet-Gaudelus I; Thumerelle C; Prevotat A; Rosner V; Clement A; Corvol H
Respir Med; 2017 Dec; 133():12-15. PubMed ID: 29173443
[TBL] [Abstract][Full Text] [Related]
8. Treating Allergic Bronchopulmonary Aspergillosis with Short-Term Prednisone and Itraconazole in Cystic Fibrosis.
Gothe F; Schmautz A; Häusler K; Tran NB; Kappler M; Griese M
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2608-2614.e3. PubMed ID: 32147521
[TBL] [Abstract][Full Text] [Related]
9. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis.
Kraemer R; Deloséa N; Ballinari P; Gallati S; Crameri R
Am J Respir Crit Care Med; 2006 Dec; 174(11):1211-20. PubMed ID: 16959918
[TBL] [Abstract][Full Text] [Related]
10. Diverse clinical characteristics of Aspergillus growth in patients with cystic fibrosis.
Emiralioğlu N; Doğru D; Doğan Ö; Gülmez D; Akdağlı SA; Polat SE; Tuğcu G; Hızal MG; Yalçın E; Özçelik U; Şener B; Kiper N
Turk J Pediatr; 2020; 62(4):560-568. PubMed ID: 32779408
[TBL] [Abstract][Full Text] [Related]
11. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis.
Skov M; Koch C; Reimert CM; Poulsen LK
Allergy; 2000 Jan; 55(1):50-8. PubMed ID: 10696856
[TBL] [Abstract][Full Text] [Related]
13. Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis.
Armstead J; Morris J; Denning DW
PLoS One; 2014; 9(6):e98502. PubMed ID: 24914809
[TBL] [Abstract][Full Text] [Related]
14. Frequencies of pathogenic CFTR variants in Greek cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus fumigatus chronic colonization: A retrospective cohort study.
Noni M; Katelari A; Poulou M; Ioannidis D; Kapasouri EM; Tzetis M; Doudounakis SE; Kanaka-Gantenbein C; Spoulou V
J Mycol Med; 2023 Mar; 33(1):101326. PubMed ID: 36272381
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy.
Skov M; McKay K; Koch C; Cooper PJ
Respir Med; 2005 Jul; 99(7):887-93. PubMed ID: 15939251
[TBL] [Abstract][Full Text] [Related]
16. Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.
Nové-Josserand R; Grard S; Auzou L; Reix P; Murris-Espin M; Brémont F; Mammar B; Mely L; Hubert D; Durieu I; Burgel PR
Pediatr Pulmonol; 2017 Feb; 52(2):190-197. PubMed ID: 27717223
[TBL] [Abstract][Full Text] [Related]
17. [Allergic bronchopulmonary aspergillosis disclosing mucoviscidosis].
Coltey B; Pin I; Ferretti G; Bonadona A; Pison C; Brambilla C
Rev Mal Respir; 2001 Oct; 18(5):549-51. PubMed ID: 11887775
[TBL] [Abstract][Full Text] [Related]
18. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy.
Hemmann S; Nikolaizik WH; Schöni MH; Blaser K; Crameri R
Eur J Immunol; 1998 Apr; 28(4):1155-60. PubMed ID: 9565354
[TBL] [Abstract][Full Text] [Related]
19. Disseminated aspergillosis in a patient with cystic fibrosis and allergic bronchopulmonary aspergillosis.
Chung Y; Kraut JR; Stone AM; Valaitis J
Pediatr Pulmonol; 1994 Feb; 17(2):131-4. PubMed ID: 8165040
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis.
Koutsokera A; Corriveau S; Sykes J; Coriati A; Cortes D; Vadas P; Chaparro C; McIntyre K; Tullis E; Stephenson AL
J Cyst Fibros; 2020 Jan; 19(1):119-124. PubMed ID: 31405730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]